Herbert Smith Freehills Kramer advises on DKSH’s acquisition of NewBridge Pharmaceuticals
Herbert Smith Freehills Kramer has advised DKSH, a leading provider of market expansion services, on its acquisition of NewBridge Pharmaceuticals, a Dubai-headquartered healthcare commercialisation platform focused on specialty and rare disease medicines in the Middle East...







































































































































